Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Isolating cells expressing secreted proteins

a technology of secreted proteins and cells, applied in the field of identification and isolating cells, can solve the problems of insufficient available methods, risks of losing high expression cells, laborious procedures, etc., and achieve the effect of facilitating the detection and/or isolating of cells

Inactive Publication Date: 2005-08-25
REGENERON PHARM INC
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention describes a method for quickly identifying and isolating cells that produce a specific protein by directly screening for the protein on the surface of cells. This method can be used to detect and isolate cells that produce any secreted protein, including antibodies. It allows for the convenient monitoring of cells that secrete the protein of interest (POI) during the manufacturing process. The invention also allows for the isolation of rare cells that produce the desired protein. The method can be applied to transgenic animals and can be used to detect and isolate cells that produce any secreted protein. Overall, this invention provides a faster and more efficient way to identify and isolate cells that produce specific proteins.

Problems solved by technology

These procedures are laborious, inefficient, expensive, and the number of clones that can be analyzed is usually limited to a few hundred.
Moreover, the collection of clone pools, or hand-picked colonies, risks losing high expression cells, which often grow more slowly, to faster growing low expression cells.
Incorporation of flow cytometry into methods used for the isolation of stable expression cell lines has improved the capability of screening large numbers of individual clones, however, currently available methods remain inadequate for diverse reasons.
Diffusion of the POI between cells of different characteristics was also a problem.
Because this method depends on the coupling of GOI expression to the reporter gene by use of an IRES in a recombinant construction, it is not applicable to the isolation of hybridomas.
Moreover, use of flow cytometry significantly reduces the direct handling of cells.
Unfortunately, the level of GFP production is not a direct measure of the production level of the POI.
Moreover, some cells may be sensitive to the encapsulation process.
However, diffusion of POI between neighboring cells is problematic, and this method also requires a high viscosity medium to reduce diffusion of POI away from expressing cells.
The problems associated with identification and isolation of high expression recombinant cell lines especially applies to the isolation of hybridomas that express an antibody of interest.
However, the identification of useful hybridomas includes several additional problems; they must be screened first for antigen-binding activity, then for immunoglobulin isotype.
Moreover, GFP-based methods are not applicable to the identification and isolation of hybridomas because construction of hybridomas does not include a recombinant construct such that expression of the antibody genes can be linked to a transcriptional reporter such as GFP.
Hybridoma screening is a slow, laborious endeavor where the number of clones screened is limited by existing technologies.
A similar problem involves the selection of rare cells producing an antibody, an ScFv, a fragment thereof, or anything fused to an antibody constant region, with a desired specificity, isotype, and avidity for a particular antigen, from a heterogeneous population of cells expressing different antibodies, ScFvs, fragments thereof, or anything fused to antibody constant regions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Isolating cells expressing secreted proteins
  • Isolating cells expressing secreted proteins
  • Isolating cells expressing secreted proteins

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0143] Construction of pTE084: pTE084 was constructed by ligating the 1,436 bp Xba I fragment from pCAE100 that encodes the human FcγRI (hFcγRI; GenBank accession number M21091) into the Xba I site of pRG821. The orientation of hFcγRI in desirable plasmids resulting from the ligation was examined by restriction mapping with Not I, Pst I, Eco RI, and Stu I. pTE084 was designed for the high level expression of hFcγRI, the high affinity cell surface receptor for the Fc domain of human IgG. It contains two independent expression cassettes. One cassette is a hFcγRI gene driven by the CMV-MIE promoter, and the second cassette is the neomycin phosphotransferase II (npt) gene, which confers resistance to G418, driven by the SV40 late promoter.

[0144] Construction of a CHO K1 derivative that expresses hFcγRI:

[0145] CHO K1 cells (4×106) were transfected with pTE084 using Lipofectamine™ (Life Technologies; Rockville, Md.) following manufacturer's suggestions. The cells were placed in the cult...

example 2

[0148] Cell surface fluorescence correlates with the expression level of 4SC622: RGC1 cells (4×106) were transfected with pEE14.1-622 and a pool of stable transfectants was obtained after selection for 2 weeks in medium comprised of 10% dialyzed fetal bovine serum, 90% glutamine-free Dulbecco's modified eagle's medium, 1×GS supplement, and 25 uM MSX (All reagents were from JRH Biosciences, Lenexa, Kans.). Rat IgG was added to the culture medium to 1 mg / ml 18 hours prior to immunostaining. The cells were trypsinized, washed with PBS, and stained with 1.5 ug / ml of a polyclonal FITC-conjugated anti-human IgG (H+L) F(ab′)2 fragment (Jackson ImmunoResearch Laboratories) for one hour at room temperature following procedures as described for FITC-hFc staining in Example 1. Cell staining was then analyzed by flow cytometry. The distribution of fluorescence suggested that the selected pool contained cells with a wide range of 4SC622 expression levels (FIG. 6). Cells in the top 3% (R3 bracket...

example 3

[0149] Isolation of Expression Clones in RGC1:

[0150] IL-4 Trap. To directly demonstrate the efficiency in generating clonal cell lines with high level secreted protein production by our methodology, clonal 4SC622 producing cell lines were generated from RGC1. RGC1 cells (4×106) were transfected with pEE14.1-622, and selected for two weeks with 25 μM MSX to obtain a pool of stable transfectants. MSX-resistant cells were pooled and incubated with 1 mg / ml human IgG for 18 hours, prior to staining with PE-AG184. Six cells from the top 5% gate, as determined by flow cytometry analysis of cell surface 4SC622 staining, were isolated and expanded. 4SC622 production from the six clonal lines was determined and compared to 4SC622 production from clones obtained by hand-picking selected colonies followed by dilution cloning and amplification. One RGC1-derived clone, RGC4, produced 4SC622 at 12 pg / cell / day (FIG. 7). This level is similar to that of the best 4SC622 producer isolated by hand-pic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
degree of heterogeneityaaaaaaaaaa
fluorescent proteinaaaaaaaaaa
stabilityaaaaaaaaaa
Login to View More

Abstract

A method for identifying and isolating cells which produce secreted proteins. This method is based upon a specific characteristic or the expression level of the secreted protein by transiently capturing the secreted protein on the surface of an individual cell, allowing selection of rare cell clones from a heterogeneous population. Also provided is the use of this method to generate cells which produce a desired level of secreted protein or secreted protein of a particular characteristic(s), and organisms which possess such cells. In particular, the method allows rapid isolation of high expression recombinant antibody-producing cell lines, or may be applied directly to rapid isolation of specific hybridomas, or to the isolation of antibody-producing transgenic animals. This method is applicable for any cell which secretes protein.

Description

[0001] This application claims priority to U.S. provisional application No. 60 / 261,999, filed Jan. 16, 2001. Throughout this application various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application.FIELD OF THE INVENTION [0002] The field of this invention is a method for identifying and isolating cells which produce secreted proteins. This method is based upon a specific characteristic or the expression level of the secreted protein by transiently capturing the secreted protein on the surface of an individual cell, allowing selection of rare cell clones from a heterogeneous population. The field also encompasses the use of this method to generate cells which produce a desired level of secreted protein or secreted protein of a particular characteristic(s), and organisms which possess such cells. In particular, the method allows rapid isolation of high expression recombinant antibody-producing...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/315C07K14/52C07K16/28C12N5/10A01K67/027C12N15/09C40B30/04G01N33/569G01N33/68
CPCA01K2217/05A01K2267/01C07K14/315C07K14/52C07K16/2863G01N2500/10C07K2319/00C12N15/1051C40B30/04G01N33/56966G01N33/6845C07K2317/77
Inventor FANDL, JAMESSTAHL, NEILCHEN, GANGYANCOPOULOS, GEORGE
Owner REGENERON PHARM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products